Plain-English translation of NCT07341932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a new heart scan called magnetocardiography (or MCG) can help doctors decide whether you need an invasive procedure or can manage your heart condition with medication alone. Right now, doctors make these decisions using older methods like stress tests and the degree of blockage seen on CT scans. The trial wants to know if this newer scanning technology can help avoid unnecessary procedures and improve your quality of life.
Many patients with partially clogged heart arteries don't actually need invasive procedures, but current methods sometimes recommend them anyway. This trial is testing whether the new scan can more accurately identify which patients truly need a procedure and which can safely manage their condition with medication and lifestyle changes, potentially reducing unnecessary procedures and costs.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either get the new magnetocardiography scan to guide your treatment, or receive standard care based on your current test results. Depending on which group you're in, your doctor will then recommend either an invasive procedure or medical management with medications. After enrollment, you'll receive phone follow-up calls at 90 days, 6 months, and 1 year to check on how you're doing, any heart problems you've had, your symptoms, and healthcare costs. The study will last one year.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
China